Adaptive cancelation of self-generated sensory signals in a whisking robot

Sensory signals are often caused by one's own active movements. This raises a problem of discriminating between self-generated sensory signals and signals generated by the external world. Such discrimination is of general importance for robotic systems, where operational robustness is dependent on the correct interpretation of sensory signals. Here, we investigate this problem in the context of a whiskered robot. The whisker sensory signal comprises two components: one due to contact with an object (externally generated) and another due to active movement of the whisker (self-generated). We propose a solution to this discrimination problem based on adaptive noise cancelation, where the robot learns to predict the sensory consequences of its own movements using an adaptive filter. The filter inputs (copy of motor commands) are transformed by Laguerre functions instead of the often-used tapped-delay line, which reduces model order and, therefore, computational complexity. Results from a contact-detection task demonstrate that false positives are significantly reduced using the proposed scheme

Microfluidic rheometry

The development and growth of microfluidics has stimulated interest in the behaviour of complex liquids in micro-scale geometries and provided a rich platform for rheometric investigations of non-Newtonian phenomena at small scales. Microfluidic techniques present the rheologist with new opportunities for material property measurement and this review discusses the use of microfluidic devices to measure bulk rheology in both shear and extensional flows. Capillary, stagnation and contraction flows are presented in this context and developments, limitations and future perspectives are examined

Anti‐Oxidants Improve Factor Viii Folding And Secretion And Reduce Cell Toxicity And Inflammation In Vivo In Mice

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106094/1/jth02905.pd

Fingerprinting Soft Materials: A Framework for Characterizing Nonlinear Viscoelasticity

We introduce a comprehensive scheme to physically quantify both viscous and elastic rheological nonlinearities simultaneously, using an imposed large amplitude oscillatory shear (LAOS) strain. The new framework naturally lends a physical interpretation to commonly reported Fourier coefficients of the nonlinear stress response. Additionally, we address the ambiguities inherent in the standard definitions of viscoelastic moduli when extended into the nonlinear regime, and define new measures which reveal behavior that is obscured by conventional techniques.Comment: 10 pages, 3 figures, full-page double-space preprint forma

Clinical Considerations for Capsid Choice in the Development of Liver-Targeted AAV-Based Gene Transfer

As gene transfer with adeno-associated virus (AAV) vectors is starting to enter clinical practice, this review examines the impact of vector capsid choice in liver-directed gene transfer for hemophilia. Given that there are multiple clinical trials completed and ongoing in this field, it is important to review the clinical evidence, particularly as a range of AAV-vector serotypes including AAV2, AAV5, AAV8, and AAV10 have been tested. Although there have been a number of successful trials, the development of two investigational AAV vectors for hemophilia B has been discontinued because they did not meet efficacy and/or safety expectations. Whether this difference between success and failure of gene transfer approaches reflects capsid choice, vector design, manufacturing system, or other variables is a question of great interest. Here, we examine the body of evidence across trials to determine the possible influences of serotype choice on key clinical outcomes such as safety, vector clearance, treatment eligibility, occurrence of transaminase elevations, activation of capsid-directed cytotoxic T cell responses, and clinical efficacy. In summary, gene transfer requires a balance between achieving sufficient transgene expression and minimizing destructive immune responses, which may be affected by AAV-vector serotype choice

New high-technology products for the treatment of haemophilia

This review will focus on new technologies in development that promise to lead to further advances in haemophilia therapeutics. There has been continued interest in the bioengineering of recombinant factor VIII (rFVIII) and factor IX (rFIX) with improved function to overcome some of the limitations in current treatment, the high costs of therapy and to increase availability to a broader world haemophilia population. Bioengineered forms of rFVIII, rFIX or alternative haemostatic molecules may ultimately have an impact on improving the efficacy of therapeutic strategies for the haemophilias by improving biosynthesis and secretion, functional activity, half-life and immunogenicity. Preventing and suppressing inhibitors to factor (F) VIII remain a challenge for both clinicians and scientists. Recent experiments have shown that it is possible to obtain anti-idiotypic antibodies with a number of desirable properties: (i) strong binding avidity to FVIII inhibitors; (ii) neutralization of inhibitory activity both in vitro and in vivo ; (iii) cross-reactivity with antibodies from unrelated patients, and (iv) no interference with FVIII function. An alternative, although complementary approach, makes use of peptides derived from filamentous-phage random libraries. Mimotopes of FVIII can be obtained, which bind to the paratope of inhibitory activity and neutralize their activity both in vitro and in vivo . In this paper, we review advanced genetic strategies for haemophilia therapy. Until recently the traditional concept for gene transfer of inherited and acquired haematological diseases has been focused on how best to obtain stable insertion of a cDNA into a target-cell genome, allowing expression of a therapeutic protein. However, as gene-transfer vector systems continue to improve, the requirement for regulated gene transcription and hence regulated protein expression will become more critical. Inappropriate protein expression levels or expression of transferred cDNAs in non-intended cell types or tissues may lead to target-cell toxicity or activation of unwanted host immune responses. Regulated protein expression requires that the transferred gene be transferred with its own regulatory cassette that allows for gene transcription and translation approaching that of the normal gene in its endogenous context. New molecular techniques, in particular the use of RNA molecules, now allow for transcription of corrective genes that mimic the normal state.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/75577/1/j.1365-2516.2004.00996.x.pd

Microfluidic extensional rheometry using a hyperbolic contraction geometry

Microfluidic devices are ideally suited for the study of complex fluids undergoing large deformation rates in the absence of inertial complications. In particular, a microfluidic contraction geometry can be utilized to characterize the material response of complex fluids in an extensionally-dominated flow, but the mixed nature of the flow kinematics makes quantitative measurements of material functions such as the true extensional viscosity challenging. In this paper, we introduce the ‘extensional viscometer-rheometer-on-a-chip’ (EVROC), which is a hyperbolically-shaped contraction-expansion geometry fabricated using microfluidic technology for characterizing the importance of viscoelastic effects in an extensionally-dominated flow at large extension rates (λ[. over ε][subscript a] ≫ 1, where λ is the characteristic relaxation time, or for many industrial processes . over ε][subscript a] ≫ 1 s[superscript −1]). We combine measurements of the flow kinematics, the mechanical pressure drop across the contraction and spatially-resolved flow-induced birefringence to study a number of model rheological fluids, as well as several representative liquid consumer products, in order to assess the utility of EVROC as an extensional viscosity indexer.National Science Foundation (U.S.). Graduate Research FellowshipUnited States. National Aeronautics and Space Administration (Microgravity Fluid Sciences Grant NNX09AV99G)European Commission. Marie Curie Actions (FP7-PEOPLE-2011-IIF Grant 298220

Efficient Secretion Of Bioengineered Coagulation Factor Viii Into The Milk Of Transgenic Animals

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106071/1/jth01670.pd

MCFD2, a second gene defective in combined factor V/factor VIII deficiency, encodes a novel ER protein that interacts with LMAN1 (ERGIC‐53) to form a cofactor‐specific sorting receptor

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106096/1/jth03926.pd